NCT00005094View on ClinicalTrials.gov

Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps

PHASE3CompletedINTERVENTIONAL
Enrollment

1,170

Participants

Timeline

Start Date

March 31, 2000

Primary Completion Date

April 30, 2006

Conditions
Colon CancerRectal Cancer
Interventions
DRUG

celecoxib

Given orally

OTHER

placebo

Given orally

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00005094 - Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps | Biotech Hunter | Biotech Hunter